Is continuation of levothyroxine treatment in older adults always necessary?Study determines the proportion of adults aged 60 years or older who can successfully discontinue levothyroxine treatment. These patients without drug coverage are eagerly awaiting generic Ozempic in CanadaLower-cost alternatives could soon expand access for Canadians priced out of a popular drug. Mirtazapine shows some benefit in the treatment of methamphetamine use disorder Study examines the efficacy and safety of daily mirtazapine to treat moderate to severe methamphetamine use disorder in outpatients. Rare, severe skin reaction can happen with wide variety of drugs Acute generalized exanthematous pustulosis (AGEP). Treating psoriasis: Take the elevator, not the stairs Instead of offering biologic therapies only when all other treatments have failed, why not start them as soon as psoriasis symptoms appear? POP QUIZ: Jornay PM for ADHD Which statement about Jornay PM, a new formulation of methylphenidate for the treatment of attention-deficit hyperactivity disorder, is FALSE? Alberta regulator reminds pharmacies of ephedrine, pseudoephedrine rules Federal update doesn’t change how products are stored or sold, says the Alberta College of Pharmacy. Pharmacist-led cancer clinic is a 'lifesaver' as oral therapies surge Waterloo clinic embeds pharmacists into oncology teams, easing pressure as more patients shift to oral anticancer drugs. 'Theft is a criminal offence': ACP warns about the dangers of diverting medication Alberta pharmacy regulator sends reminder to members after suspending technician who took controlled substances for personal use. Two new developments in the prevention of hereditary angioedema attacks New drug Andembry (garadacimab SC injection) is now available and Takhzyro (lanadelumab SC injection) is now approved in a new format and expanded age range. 1 2 3 4 5 Next Last
